During the past decade, Herman Clinical Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Herman Clinical Research" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Urinary Bladder Diseases" (1 trials), "Urinary Bladder Overactive" (1 trials) and "Urologic Diseases" (1 trials). Many other conditions were trialed in "Herman Clinical Research" in a lesser frequency.

Most popular intervention types in "Herman Clinical Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Obicetrapib" (1 trials), "Placebo" (1 trials), "mirabegron 25 mg" (1 trials), "mirabegron 25 mg matching placebo" (1 trials) and "mirabegron 50 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herman Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Herman Clinical Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Herman Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Herman Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".